128 related articles for article (PubMed ID: 10666686)
1. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease.
Yoo BC; Seidl R; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():315-22. PubMed ID: 10666686
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease.
Hermon M; Cairns N; Egly JM; Fery A; Labudova O; Lubec G
Neurosci Lett; 1998 Jul; 251(1):45-8. PubMed ID: 9714461
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome.
Fountoulakis M; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():323-35. PubMed ID: 10666687
[TBL] [Abstract][Full Text] [Related]
4. Heat-shock 70 messenger RNA levels in human brain: correlation with agonal fever.
Morrison-Bogorad M; Zimmerman AL; Pardue S
J Neurochem; 1995 Jan; 64(1):235-46. PubMed ID: 7798918
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K; Kakulas BA
J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
[TBL] [Abstract][Full Text] [Related]
6. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level.
Lubec G; Nonaka M; Krapfenbauer K; Gratzer M; Cairns N; Fountoulakis M
J Neural Transm Suppl; 1999; 57():161-77. PubMed ID: 10666674
[TBL] [Abstract][Full Text] [Related]
7. Thyroid stimulating hormone-receptor overexpression in brain of patients with Down syndrome and Alzheimer's disease.
Labudova O; Cairns N; Koeck T; Kitzmueller E; Rink H; Lubec G
Life Sci; 1999; 64(12):1037-44. PubMed ID: 10210286
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease.
Bajo M; Yoo BC; Cairns N; Gratzer M; Lubec G
Amino Acids; 2001; 21(3):293-301. PubMed ID: 11764410
[TBL] [Abstract][Full Text] [Related]
9. Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease.
Brooksbank BW; Martinez M
Mol Chem Neuropathol; 1989 Dec; 11(3):157-85. PubMed ID: 2534986
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of molecular chaperones in brain of patients with Down syndrome.
Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
[TBL] [Abstract][Full Text] [Related]
11. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome.
Shim KS; Lubec G
Neurosci Lett; 2002 May; 324(3):209-12. PubMed ID: 12009525
[TBL] [Abstract][Full Text] [Related]
12. Brain vasopressin levels in Down syndrome and Alzheimer's disease.
Labudova O; Fang-Kircher S; Cairns N; Moenkemann H; Yeghiazaryan K; Lubec G
Brain Res; 1998 Sep; 806(1):55-9. PubMed ID: 9739107
[TBL] [Abstract][Full Text] [Related]
13. Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome.
Gulesserian T; Engidawork E; Cairns N; Lubec G
Neurosci Lett; 2000 Dec; 296(1):53-7. PubMed ID: 11099832
[TBL] [Abstract][Full Text] [Related]
14. Serotonin (5-HT) in brains of adult patients with Down syndrome.
Seidl R; Kaehler ST; Prast H; Singewald N; Cairns N; Gratzer M; Lubec G
J Neural Transm Suppl; 1999; 57():221-32. PubMed ID: 10666678
[TBL] [Abstract][Full Text] [Related]
15. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.
Yoo BC; Cairns N; Fountoulakis M; Lubec G
Dement Geriatr Cogn Disord; 2001; 12(3):219-25. PubMed ID: 11244216
[TBL] [Abstract][Full Text] [Related]
16. c-fos expression in brains of patients with Down syndrome.
Greber-Platzer S; Balcz B; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():75-85. PubMed ID: 10666669
[TBL] [Abstract][Full Text] [Related]
17. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
Vlkolinský R; Cairns N; Fountoulakis M; Lubec G
Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
[TBL] [Abstract][Full Text] [Related]
18. Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease.
Ross GW; O'Callaghan JP; Sharp DS; Petrovitch H; Miller DB; Abbott RD; Nelson J; Launer LJ; Foley DJ; Burchfiel CM; Hardman J; White LR
Acta Neurol Scand; 2003 May; 107(5):318-23. PubMed ID: 12713522
[TBL] [Abstract][Full Text] [Related]
19. Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease.
Brooksbank BW; McGovern J
Mol Chem Neuropathol; 1989 Dec; 11(3):143-56. PubMed ID: 2534985
[TBL] [Abstract][Full Text] [Related]
20. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
